Physicochemical Properties Affecting Retinal Drug/Coumarin-6 Delivery from Nanocarrier Systems via Eyedrop Administration

被引:72
作者
Inokuchi, Yuta [1 ]
Hironaka, Kohei [2 ]
Fujisawa, Takuya [2 ]
Tozuka, Yuichi [2 ]
Tsuruma, Kazuhiro [1 ]
Shimazawa, Masamitsu [1 ]
Takeuchi, Hirofumi [2 ]
Hara, Hideaki [1 ]
机构
[1] Gifu Pharmaceut Univ, Dept Biofunct Evaluat, Gifu 5011196, Japan
[2] Gifu Pharmaceut Univ, Dept Drug Delivery Technol & Sci, Gifu 5011196, Japan
关键词
OCULAR DRUG-DELIVERY; CYTOMEGALOVIRUS RETINITIS; GANCICLOVIR IMPLANT; POSTERIOR SEGMENT; IN-VIVO; NANOPARTICLES; LIPOSOMES; RABBITS; INDOMETHACIN; RANIBIZUMAB;
D O I
10.1167/iovs.09-4697
中图分类号
R77 [眼科学];
学科分类号
100212 ;
摘要
PURPOSE. To elucidate the effect of physicochemical properties of nanocarrier systems on drug delivery efficiency to the retina by eyedrop administration in mice, rabbits, and monkeys. METHODS. Submicron-sized liposomes (ssLips) of different particle size, cholesterol content, surface charge, and multilamellar vesicles (MLV) were prepared by the hydration method. Fluorescence probe (coumarin-6)-incorporated liposomes, lipid emulsions, and FITC-labeled polystyrene particles were used to investigate their intraocular behavior after eyedrop administration, using epifluorescence microscopy in mice, rabbits, and monkeys. RESULTS. Delivery efficiency of fluorescent probes to the mouse retina from dropped liposomes was extensively improved by reducing their particle size (<600 nm) and cholesterol content, whereas negligible improvement was observed in the case of MLV. Furthermore, FITC-labeled polystyrene particles and coumarin-6-incorporated lipid emulsions showed an insufficient effect on retinal delivery in mice even if their size was controlled at 110 nm. The highest accumulation of the fluorescent probe in the retina was observed around 30 minutes with any type of ssLip used, followed by the prompt disappearance of their fluorescence within 120 minutes in mice. Changes in the fluorescence intensity of coumarin-6 in rabbits and monkeys were observed in a manner similar to that described in mice. Retinal flat-mount images suggest that coumarin-6 incorporated in ssLip diffused from the iris and ciliary body side to the optic disc side in the retina after eyedrop administration. CONCLUSIONS. The delivery efficiency of coumarin-6 to the retina was altered depending on particle size, constituents, and rigidity. ssLips with appropriate features would be promising drug carriers for retinal delivery through eyedrops. (Invest Ophthalmol Vis Sci. 2010;51:3162-3170) DOI:10.1167/iovs.09-4697
引用
收藏
页码:3162 / 3170
页数:9
相关论文
共 33 条
[21]   Colloidal carriers for ophthalmic drug delivery [J].
Mainardes, RM ;
Urban, MCC ;
Cinto, PO ;
Khalil, NM ;
Chaud, MV ;
Evangelista, RC ;
Gremiao, MPD .
CURRENT DRUG TARGETS, 2005, 6 (03) :363-371
[22]  
Marti-Mestres G, 2002, J DISPER SCI TECHNOL, V23, P419, DOI 10.1080/01932690208984214
[23]   Review: Practical issues in intravitreal drug delivery [J].
Maurice, D .
JOURNAL OF OCULAR PHARMACOLOGY AND THERAPEUTICS, 2001, 17 (04) :393-401
[24]   A novel method for measuring rigidity of submicron-size liposomes with atomic force microscopy [J].
Nakano, Koji ;
Tozuka, Yuichi ;
Yamamoto, Hiromitsu ;
Kawashima, Yoshiaki ;
Takeuchi, Hirofumi .
INTERNATIONAL JOURNAL OF PHARMACEUTICS, 2008, 355 (1-2) :203-209
[25]   PILOCARPINE INCORPORATED INTO A SUBMICRON EMULSION VEHICLE CAUSES AN UNEXPECTEDLY PROLONGED OCULAR HYPOTENSIVE EFFECT IN RABBITS [J].
NAVEH, N ;
MUCHTAR, S ;
BENITA, S .
JOURNAL OF OCULAR PHARMACOLOGY, 1994, 10 (03) :509-520
[26]   Nanotechnology in ocular drug delivery [J].
Sahoo, Sanjeeb K. ;
Diinawaz, Fahirna ;
Krishnakumar, S. .
DRUG DISCOVERY TODAY, 2008, 13 (3-4) :144-151
[27]  
Scheppke L, 2008, J CLIN INVEST, V118, P2337, DOI [10.1172/JC133361, 10.1172/JCI33361]
[28]   In vivo pachymetry in normal eyes of rats, mice and rabbits with the optical low coherence reflectometer [J].
Schulz, D ;
Iliev, ME ;
Frueh, BE ;
Goldblum, D .
VISION RESEARCH, 2003, 43 (06) :723-728
[29]   Endophthalmitis after ganciclovir implant in patients with AIDS and cytomegalovirus retinitis [J].
Shane, TS ;
Martin, DF .
AMERICAN JOURNAL OF OPHTHALMOLOGY, 2003, 136 (04) :649-654
[30]  
Shimazawa M, 2007, MOL VIS, V13, P578